Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat model

Koc Kan Ho, James R. Beasley, Laura Belanger, Darcey Black, Jui Hsiang Chan, David Dunn, Bing Hu, Anthony Klon, Steven G. Kultgen, Michael Ohlmeyer, Susan M. Parlato, Peter C. Ray, Quynhchi Pham, Yajing Rong, Andrew L. Roughton, Tiffany L. Walker, Jane Wright, Kai Xu, Yan Xu, Limei ZhangMaria Webb

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

The profile of a series of triazine and pyrimidine based ROCK inhibitors is described. An initial binding mode was established based on a homology model and the proposed interactions are consistent with the observed SAR. Compounds from the series are potent in a cell migration assay and possess a favorable kinase selectivity. In vivo activity was demonstrated for compound 1A in a spontaneous hypertensive rat model.

Original languageEnglish
Pages (from-to)6027-6031
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number21
DOIs
StatePublished - 1 Nov 2009
Externally publishedYes

Keywords

  • Homology model
  • Hypertension
  • Pyrimidine
  • ROCK
  • Triazine

Fingerprint

Dive into the research topics of 'Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat model'. Together they form a unique fingerprint.

Cite this